An open-label, randomised, parallel clinical research evaluating the safety and efficacy of methotrexate and apremilast in patients with moderate to severe palm plantar psoriasis. Int. Res. J. Pharm. [Internet]. 2027 Jul. 27 [cited 2026 Aug. 3];15(7):8-18. Available from: https://irjponline.org/index.php/irjp/article/view/3131